loading

Finch Therapeutics Group Inc Azioni (FNCH) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - 0.107
Operating Expenses
17.71%
5.198
4.416 3.781 9.881 67.48
Operating Income/Loss
17.71%
-5.198
-4.416 -3.781 -9.881 -67.38
Nonoperating Income/Loss
3.85%
1.322
1.375 1.365 2.931 -0.025
Income/Loss From Continuing Operations Before Tax
27.46%
-3.876
-3.041 -2.416 -6.95 -67.40
Income Tax Expense/Benefit, Deferred
-
- - - -3.461
Income Tax Expense/Benefit
-
- - - -3.461
Income/Loss From Continuing Operations After Tax
27.46%
-3.876
-3.041 -2.416 -6.95 -62.35
Net Income/Loss
27.46%
-3.876
-3.041 -2.416 -6.95 -63.94
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
461.33K%
1.6058
0.000348 1.605 1.6048 48.09
Diluted Average Shares
461.33K%
1.6058
0.000348 1.605 1.6048 48.09
Basic Earnings Per Share
27.51%
-2.41
-1.89 -1.51 -4.33 -1.33
Diluted Earnings Per Share
27.51%
-2.41
-1.89 -1.51 -4.33 -1.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):